NCT01664754 Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01653470 Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens; Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01652794 Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer Status COMPLETED Phase PHASE1
NCT01650376 Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT01649947 Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II Status COMPLETED Phase PHASE2
NCT01644955 Carboplatin in Treating Patients With Recurrent High-Grade Gliomas Status COMPLETED Phase PHASE1
NCT01633970 A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01633541 Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer Status COMPLETED Phase PHASE2
NCT01624493 BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT01617928 A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT01616303 A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01612351 Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery Status COMPLETED Phase PHASE2
NCT01602666 Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT01593228 Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial Status COMPLETED Phase PHASE3
NCT01590732 Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT01578551 Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. Status TERMINATED Phase PHASE2